Luye Pharma Group Limited — Regulatory Filings 2021

Aug 17, 2021

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [194 x 87] intentionally omitted <==

LUYE PHARMA GROUP LTD.

綠 葉 製 藥 集 團 有 限 公 司

(Incorporated in Bermuda with limited liability)

(Stock Code: 02186)

NOTICE OF BOARD MEETING

The board of directors (the ‘‘Board’’) of Luye Pharma Group Ltd. (the ‘‘Company’’) hereby announces that a meeting of the Board will be held on Friday, 27 August 2021, for the purpose of, among other matters, approving the interim results of the Company and its subsidiaries for the six months ended 30 June 2021 and its publication and considering the payment of an interim dividend, if any.

By order of the Board LUYE PHARMA GROUP LTD. Liu Dian Bo Chairman

Hong Kong, 17 August 2021

As at the date of this announcement, the executive directors of the Company are Mr. LIU Dian Bo, Mr. YANG Rong Bing, Mr. YUAN Hui Xian and Ms. ZHU Yuan Yuan; the non-executive directors of the Company are Mr. SONG Rui Lin and Mr. SUN Xin; and the independent non-executive directors of the Company are Mr. ZHANG Hua Qiao, Professor LO Yuk Lam, Mr. LEUNG Man Kit and Mr. CHOY Sze Chung Jojo.